South Africa:  Samsung applying deep learning technology to ultrasound imaging

South Africa: Samsung applying deep learning technology to ultrasound imaging

To meet the growing demand for faster and more efficient diagnostic imaging, Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, announced  in South Africa that it is applying deep learning technology to ultrasound imaging in breast lesion analysis for the first time.
The premium ultrasound RS80A is a radiology-designated ultrasound system that provides advanced technologies for accurate diagnosis. With its outstanding features as well as accurate imaging and comfortable ergonomic design, you can be assured it will provide exceptional results when and where you need it. RS80A with Prestige’s latest upgrade includes ‘S-DetectTM’ (Smart-Detect) for breast, which now employs an algorithm as well as other imaging enhancements and diagnostic functions designed for radiologists such as Fusion and Contrast-enhanced ultrasound (CEUS) imaging.

S-Detect for breast utilises big data collected from numerous breast exam cases and provides the characteristics of the displayed lesion as well as a recommendation on whether the selected lesion is benign or malignant. By adopting a learning based on a set of algorithms in lesion segmentation, characteristic analysis and assessment processes, users are now provided with more accurate results.

“Samsung Medison identified a high level of conformity from analysing and detecting lesion in various cases by using the S-Detect,” said Mike van Lier, Director of Enterprise Business Division at Samsung Electronics South Africa. “Users can reduce unnecessary biopsies and doctors-in-training will likely have more reliable support in accurately detecting malignant and suspicious lesions.”

The other key upgrades of the RS80A with Prestige include:
Enhanced Workflow and Imaging for Radiologists
* ‘Smart Fusion’ now provides ‘Respiration Auto’ function that minimises the registration gap between real-time ultrasound and recorded Computed Tomography and Magnetic Resonance Imaging (CT/MRI) images, which is caused by the difference in images when the patient inhales and exhales.
* CEUS+ applies Samsung’s ‘VesselMax’ and ‘FlowMax’ to generate clear visualisation of vessels and blood flow when viewing ultrasound images with contrast agents.
* ‘Smart-3D Arterial Analysis’ enables 3D imaging of vessels and provides volume measurement of artery plaque in a simplified way. Users can also track the morphological changes of the artery.

We suggest you read  Uganda: ClinicCommunicator brings closer to patient via mobile phones

Advanced Display Technology
* ‘Smart Harmonic’ generates greater image conformity from near to far field while reducing signal noise based on wider bandwidths and higher frequency.
* HQ Vision visualises anatomical structures with improved clarity. It helps make a reliable diagnosis especially for MSK (Musculoskeletal) imaging such as tendon and muscles.
Since its first launch in 2014, the RS80A has been providing users with easy, fast and accurate diagnosis around the world including various medical institutions such as Mayo Clinic (US) and Charité University Hospital (Germany). The latest RS80A with Prestige is now available in South Africa.
“Samsung is moving forward in the healthcare market by not only utilising its IT and display technology, but also bringing new software solutions to ultrasound diagnosis like S-Detect,” adds Van Lier. “With our leading software technology, we will continue to develop advanced imaging functions for users to experience faster and more confident diagnosis.”